Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Inclusion Criteria

• •Adult patients 18-74 years of age
• •Single primary liver transplant from a deceased donor
• •CellCept plus tacrolimus or cyclosporine from time of transplantation (within 72 hours)
• •Patients with hepatitis C-positive status may be entered if they have had an intraoperative (back table) biopsy of the transplanted liver or will have a biopsy at the time of randomization. This is not required for patients negative for hepatitis C.